Oral Genome has partnered with Henry Schein to expand access to its saliva tests, which analyze biomarkers to assess oral and overall health in real time.
Through Henry Schein’s distribution network, the technology will reach dental practices, health clinics, and medical offices. The partnership’s mission is to help providers detect health issues earlier and promote preventive care, according to the companies.
